FindTrial
Sign In

This is a trial to study how the molecular classification of breast cancer patients relate to their modes of presentation, biological behavior and treatment outcome.

Breast cancer classification according to immunohistochemistry markers and its relationship with clinicopathological features, treatment outcome and survival analysis.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/04/012963
Enrollment
286
Registered
2018-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Known cases of biopsy proven breast cancer in females.

Interventions

Intervention1: NOT APPLICABLE: NOT APPLICABLE Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Sponsors

Government funded Institution
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Unilateral, biopsy proven invasive ductal carcinoma(IDC) breast with baseline normal hematological, renal and hepatic profile and baseline normal cardiac and pulmonary function status. Any T, any N, M0 stage.

Exclusion criteria

Exclusion criteria: Any evidence of distant metastasis at presentation, pregnant or lactating patients, previous history of any breast malignancy, presence of serious comorbidities or deranged hematological or biochemical parameters.

Design outcomes

Primary

MeasureTime frame
Disease Free Survival, Overall Survival.Timepoint: 3 years—

Secondary

MeasureTime frame
Locoregional Free Survival, Distant Metastasis Free SurvivalTimepoint: 3years—

Countries

India

Contacts

Public ContactDr Rumeli Roy

Medical College and Hospital, Kolkata.

asitrdeb@rediffmail.com9830583960

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026